Skip to main content
SpringerLink
Log in

Digital Interventions for Relapse Prevention, Illness Self-Management, and Health Promotion In Schizophrenia: Recent Advances, Continued Challenges, and Future Opportunities

  • Review
  • Published:
Current Treatment Options in Psychiatry Aims and scope Submit manuscript

A Correction to this article was published on 17 May 2024

This article has been updated

Abstract

Purpose of Review

Schizophrenia presents a significant mental health challenge requiring innovative solutions for relapse prevention, self-management, and health promotion. Patients face an excess mortality gap, driven by increased rates of chronic health conditions, exacerbated in low-resource settings. Digital interventions are a promising avenue to address the multifaceted needs of individuals with schizophrenia. This narrative review synthesizes evidence from digital intervention trials for schizophrenia published from January 2020 to June 2023.

Recent Findings

23 studies were identified, encompassing smartphone applications and web-based platforms to mitigate symptom severity, prevent relapse, and promote physical health. Key developments thus far have shown reduced symptom burden, and enhanced medication adherence and physical activity engagement. Despite more than a decade of research on digital interventions, many trials in this review continued to focus on acceptability and feasibility, with emphasis on patient uptake. This suggests the field has shown limited advancement in effectiveness studies of digital interventions.

Summary

As the field evolves, further fully powered effectiveness studies, greater emphasis on implementation studies for digital tools for schizophrenia, and attention on digital health equity and evidence generation among those in lower-income countries are warranted. These findings hold implications for clinicians, researchers, and policymakers towards optimizing digital care for individuals with schizophrenia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1 

Similar content being viewed by others

Change history

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. No Author. “Schizophrenia.” In: World Health Organization Fact Sheets. 2022. https://www.who.int/news-room/fact-sheets/detail/schizophrenia. Accessed 21 Sep 2023.

  2. Ohi K, et al. A 1.5-Year Longitudinal Study of Social Activity in Patients With Schizophrenia. Front. Psychiatry. 2019;10. Available: https://www.frontiersin.org/articles/10.3389/fpsyt.2019.00567. Accessed 21 Sep 2023.

  3. Duțescu MM, et al. Social Functioning in Schizophrenia Clinical Correlations. Curr Health Sci J. 2018;44(2):151–6. https://doi.org/10.12865/CHSJ.44.02.10.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Olfson M, Gerhard T, Huang C, Crystal S, Stroup TS. Premature Mortality Among Adults With Schizophrenia in the United States. JAMA Psychiat. 2015;72(12):1172–81. https://doi.org/10.1001/jamapsychiatry.2015.1737.

    Article  Google Scholar 

  5. Laursen TM, Nordentoft M, Mortensen PB. Excess Early Mortality in Schizophrenia. Annu Rev Clin Psychol. 2014;10(1):425–48. https://doi.org/10.1146/annurev-clinpsy-032813-153657.

    Article  PubMed  Google Scholar 

  6. Archibald L, Brunette MF, Wallin DJ, Green AI. Alcohol Use Disorder and Schizophrenia or Schizoaffective Disorder. Alcohol Res Curr Rev. 2019;40(1). https://doi.org/10.35946/arcr.v40.1.06.

  7. Charlson FJ, et al. Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016. Schizophr Bull. 2018;44(6):1195–203. https://doi.org/10.1093/schbul/sby058.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Liu NH, et al. “Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas”, World Psychiatry Off. J World Psychiatr Assoc WPA. 2017;16(1):30–40. https://doi.org/10.1002/wps.20384.

    Article  CAS  Google Scholar 

  9. Rathod S, et al. Mental Health Service Provision in Low- and Middle-Income Countries. Health Serv Insights. 2017;10:1178632917694350. https://doi.org/10.1177/1178632917694350.

    Article  PubMed  PubMed Central  Google Scholar 

  10. He H, et al. Trends in the incidence and DALYs of schizophrenia at the global, regional and national levels: results from the Global Burden of Disease Study 2017. Epidemiol Psychiatr Sci. 2020;29:e91. https://doi.org/10.1017/S2045796019000891.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Henssler J, et al. Migration and schizophrenia: meta-analysis and explanatory framework. Eur Arch Psychiatry Clin Neurosci. 2020;270(3):325–35. https://doi.org/10.1007/s00406-019-01028-7.

    Article  PubMed  Google Scholar 

  12. Lazaridou FB, Schubert SJ, Ringeisen T, Kaminski J, Heinz A, Kluge U. Racism and psychosis: an umbrella review and qualitative analysis of the mental health consequences of racism. Eur Arch Psychiatry Clin Neurosci. 2023;273(5):1009–22. https://doi.org/10.1007/s00406-022-01468-8.

    Article  PubMed  Google Scholar 

  13. Ayano G, Tesfaw G, Shumet S. The prevalence of schizophrenia and other psychotic disorders among homeless people: a systematic review and meta-analysis. BMC Psychiatry. 2019;19(1):370. https://doi.org/10.1186/s12888-019-2361-7.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Burns JK, Tomita A, Kapadia AS. Income inequality and schizophrenia: Increased schizophrenia incidence in countries with high levels of income inequality. Int J Soc Psychiatry. 2014;60(2):185–96. https://doi.org/10.1177/0020764013481426.

    Article  PubMed  Google Scholar 

  15. Naslund JA, Aschbrenner KA. Digital technology for health promotion: opportunities to address excess mortality in persons living with severe mental disorders. Evid Based Ment Health. 2019;22(1):17–22. https://doi.org/10.1136/ebmental-2018-300034.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Ben-Zeev D, Buck B, Kopelovich S, Meller S. A technology-assisted life of recovery from psychosis. Npj Schizophr. 2019;5(1). https://doi.org/10.1038/s41537-019-0083-y.

  17. Merchant R, Torous J, Rodriguez-Villa E, Naslund JA. Digital Technology for Management of Severe Mental Disorders in Low- and Middle-Income Countries. Curr Opin Psychiatry. 2020;33(5):501–7. https://doi.org/10.1097/YCO.0000000000000626.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Fortuna KL, et al. Digital Peer Support Mental Health Interventions for People With a Lived Experience of a Serious Mental Illness: Systematic Review. JMIR Ment Health. 2020;7(4):e16460. https://doi.org/10.2196/16460.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Benoit J, Onyeaka H, Keshavan M, Torous J. Systematic Review of Digital Phenotyping and Machine Learning in Psychosis Spectrum Illnesses. Harv Rev Psychiatry. 2020;28(5):296. https://doi.org/10.1097/HRP.0000000000000268.

    Article  PubMed  Google Scholar 

  20. Martinez-Martin N. Envisioning a Path toward Equitable and Effective Digital Mental Health. AJOB Neurosci. 2022;13(3):196–8. https://doi.org/10.1080/21507740.2022.2082597.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Chivilgina O, Elger BS, Jotterand F. Digital Technologies for Schizophrenia Management: A Descriptive Review. Sci Eng Ethics. 2021;27(2):25. https://doi.org/10.1007/s11948-021-00302-z.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Rus-Calafell M, Schneider S. Are we there yet?!—a literature review of recent digital technology advances for the treatment of early psychosis. mHealth. 2020;6:3. https://doi.org/10.21037/mhealth.2019.09.14.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Naslund JA, Aschbrenner KA, Bartels SJ. Wearable Devices and Smartphones for Activity Tracking Among People with Serious Mental Illness. Ment Health Phys Act. 2016;10:10–7. https://doi.org/10.1016/j.mhpa.2016.02.001.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Armontrout J, Torous J, Fisher M, Drogin E, Gutheil T. Mobile Mental Health: Navigating New Rules and Regulations for Digital Tools. Curr Psychiatry Rep. 2016;18(10):91. https://doi.org/10.1007/s11920-016-0726-x.

    Article  PubMed  Google Scholar 

  25. No Author. Protecting users of digital mental health apps | World Economic Forum. https://www.weforum.org/impact/protecting-users-digital-mental-health-apps/. Accessed 21 Sep 2023.

  26. •• Gumley AI, et al. The EMPOWER blended digital intervention for relapse prevention in schizophrenia: a feasibility cluster randomised controlled trial in Scotland and Australia. Lancet Psychiatry. 2022;9(6):477–86. https://doi.org/10.1016/S2215-0366(22)00103-1. Large scale randomized control trial to study early relapse.

  27. •• Steare T, et al. Smartphone-delivered self-management for first-episode psychosis: the ARIES feasibility randomised controlled trial. BMJ Open. 2020;10(8):e034927. https://doi.org/10.1136/bmjopen-2019-034927. Large scale randomized control trial to study app-engagement.

  28. •• Homan P, et al. Relapse prevention through health technology program reduces hospitalization in schizophrenia. Psychol Med. 2023;53(9):4114–20. https://doi.org/10.1017/S0033291722000794. Large scale randomized control trial to study hospital re-admission rates.

  29. •• Alvarez-Jimenez M, et al. The Horyzons project: a randomized controlled trial of a novel online social therapy to maintain treatment effects from specialist first-episode psychosis services. World Psychiatry. 2021;20(2):233–43. https://doi.org/10.1002/wps.20858. Large scale randomized control trial to study social functioning.

  30. Buck B, Hallgren KA, Campbell AT, Choudhury T, Kane JM, Ben-Zeev D. mHealth-Assisted Detection of Precursors to Relapse in Schizophrenia. Front Psychiatr. 2021;12. https://doi.org/10.3389/fpsyt.2021.642200

  31. Cohen A et al. Relapse prediction in schizophrenia with smartphone digital phenotyping during COVID-19: a prospective, three-site, two-country, longitudinal study. Schizophrenia. 2023;9(1). https://doi.org/10.1038/s41537-023-00332-5.

  32. Rodriguez-Villa E, et al. Cross cultural and global uses of a digital mental health app: results of focus groups with clinicians, patients and family members in India and the United States. Glob Ment Health. 2021;8:e30. https://doi.org/10.1017/gmh.2021.28.

    Article  Google Scholar 

  33. Rodriguez-Villa E, et al. Smartphone Health Assessment for Relapse Prevention (SHARP): a digital solution toward global mental health. BJPsych Open. 2021;7(1):e29. https://doi.org/10.1192/bjo.2020.142.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Lakhtakia T, et al. Smartphone digital phenotyping, surveys, and cognitive assessments for global mental health: Initial data and clinical correlations from an international first episode psychosis study. Digit Health. 2022;8:20552076221133760. https://doi.org/10.1177/20552076221133758.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Grasa E, et al. m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability Study. JMIR Form Res. 2023;7(1):e46179. https://doi.org/10.2196/46179.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Harvey PD, Miller ML, Moore RC, Depp CA, Parrish EM, Pinkham AE. Capturing Clinical Symptoms with Ecological Momentary Assessment: Convergence of Momentary Reports of Psychotic and Mood Symptoms with Diagnoses and Standard Clinical Assessments. Innov Clin Neurosci. 2021;18(1–3):24–30.

    PubMed  PubMed Central  Google Scholar 

  37. Fortuna KL, Wright AC, Mois G, Myers AL, Kadakia A, Collins-Pisano C. Feasibility, Acceptability, and Potential Utility of Peer-supported Ecological Momentary Assessment Among People with Serious Mental Illness: a Pilot Study. Psychiatr Q. 2022;93(3):717–35. https://doi.org/10.1007/s11126-022-09986-3.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Ben-Zeev D, Buck B, Meller S, Hudenko WJ, Hallgren KA. Augmenting Evidence-Based Care With a Texting Mobile Interventionist: A Pilot Randomized Controlled Trial. Psychiatr Serv Wash DC. 2020;71(12):1218–24. https://doi.org/10.1176/appi.ps.202000239.

    Article  Google Scholar 

  39. Bell IH, et al. Pilot randomised controlled trial of a brief coping-focused intervention for hearing voices blended with smartphone-based ecological momentary assessment and intervention (SAVVy): Feasibility, acceptability and preliminary clinical outcomes. Schizophr Res. 2020;216:479–87. https://doi.org/10.1016/j.schres.2019.10.026.

    Article  PubMed  Google Scholar 

  40. Ben-Zeev D, Kaiser SM, Krzos I. Remote ‘hovering’ with individuals with psychotic disorders and substance use: feasibility, engagement, and therapeutic alliance with a text-messaging mobile interventionist. J Dual Diagn. 2014;10(4):197–203. https://doi.org/10.1080/15504263.2014.962336.e.

    Article  PubMed  PubMed Central  Google Scholar 

  41. •• Garety P, et al. Effects of SlowMo, a Blended Digital Therapy Targeting Reasoning, on Paranoia Among People With Psychosis: A Randomized Clinical Trial. JAMA Psychiat. 2021;78(7):714–25. https://doi.org/10.1001/jamapsychiatry.2021.0326. Large scale randomized control trial to study multimodal digital intervention for paranoia.

  42. •• Ben-Zeev D, et al. A Smartphone Intervention for People With Serious Mental Illness: Fully Remote Randomized Controlled Trial of CORE. J Med Internet Res. 2021;23(11):e29201. https://doi.org/10.2196/29201. Large scale trial used to reduce severity of psychiatric symptoms and disability.

  43. Ranjan T, Melcher J, Keshavan M, Smith M, Torous J. Longitudinal symptom changes and association with home time in people with schizophrenia: An observational digital phenotyping study. Schizophr Res. 2022;243:64–9. https://doi.org/10.1016/j.schres.2022.02.031.

    Article  PubMed  Google Scholar 

  44. Ghaemi SN, Sverdlov O, van Dam J, Campellone T, Gerwien R. A Smartphone-Based Intervention as an Adjunct to Standard-of-Care Treatment for Schizophrenia: Randomized Controlled Trial. JMIR Form Res. 2022;6(3):e29154. https://doi.org/10.2196/29154.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Dabit S, Quraishi S, Jordan J, Biagianti B. Improving social functioning in people with schizophrenia-spectrum disorders via mobile experimental interventions: Results from the CLIMB pilot trial. Schizophr Res Cogn. 2021;26:100211. https://doi.org/10.1016/j.scog.2021.100211.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Goldberg SB, Lam SU, Simonsson O, Torous J, Sun S. Mobile phone-based interventions for mental health: A systematic meta-review of 14 meta-analyses of randomized controlled trials. PLOS Digit Health. 2022;1(1):e0000002. https://doi.org/10.1371/journal.pdig.0000002.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Torous J, Firth J. The digital placebo effect: mobile mental health meets clinical psychiatry. Lancet Psychiatry. 2016;3(2):100–2. https://doi.org/10.1016/S2215-0366(15)00565-9.

    Article  PubMed  Google Scholar 

  48. •• Cohen EA, et al. Phase 3b Multicenter, Prospective, Open-label Trial to Evaluate the Effects of a Digital Medicine System on Inpatient Psychiatric Hospitalization Rates for Adults With Schizophrenia. J Clin Psychiatry. 2022;83(3):405412. https://doi.org/10.4088/JCP.21m14132. Large scale trial studying the implementation of digital medicine.

  49. Acosta FJ, Hernández JL, Pereira J, Herrera J, Rodríguez CJ. Medication adherence in schizophrenia. World J Psychiatry. 2012;2(5):74–82. https://doi.org/10.5498/wjp.v2.i5.74.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Strunz M, et al. Interventions to Promote the Utilization of Physical Health Care for People with Severe Mental Illness: A Scoping Review. Int J Environ Res Public Health. 2022;20(1):126. https://doi.org/10.3390/ijerph20010126.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Whiteman KL, Naslund JA, DiNapoli EA, Bruce ML, Bartels SJ. Systematic Review of Integrated Medical and Psychiatric Self-Management Interventions for Adults with Serious Mental Illness. Psychiatr Serv Wash DC. 2016;67(11):1213–25. https://doi.org/10.1176/appi.ps.201500521.

    Article  Google Scholar 

  52. •• Aschbrenner KA, et al. Group Lifestyle Intervention With Mobile Health for Young Adults With Serious Mental Illness: A Randomized Controlled Trial. Psychiatr Serv. 2022;73(2):141–8. https://doi.org/10.1176/appi.ps.202100047. Large scale trial studying two types of digital interventions for physical health.

  53. Browne J, Naslund JA, Salwen-Deremer JK, Sarcione C, Cabassa LJ, Aschbrenner KA. Factors influencing engagement in in-person and remotely delivered lifestyle interventions for young adults with serious mental illness: A qualitative study. Early Interv Psychiatry. 2023. https://doi.org/10.1111/eip.13432.

    Article  PubMed  Google Scholar 

  54. W. H. O. R. O. for Europe, “Tobacco use and mental health conditions: a policy brief,” Art. no. WHO/EURO:2020–5616–45381–64939, 2020, Accessed: Sep. 23, 2023. [Online]. Available: https://iris.who.int/handle/10665/359643.

  55. Gowarty MA, Longacre MR, Vilardaga R, Kung NJ, Gaughan-Maher AE, Brunette MF. Usability and Acceptability of Two Smartphone Apps for Smoking Cessation Among Young Adults With Serious Mental Illness: Mixed Methods Study. JMIR Ment Health. 2021;8(7):e26873. https://doi.org/10.2196/26873.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Vilardaga R, Rizo J, Palenski PE, Mannelli P, Oliver JA, Mcclernon FJ. Pilot Randomized Controlled Trial of a Novel Smoking Cessation App Designed for Individuals With Co-Occurring Tobacco Use Disorder and Serious Mental Illness. Nicotine Tob Res. 2020;22(9):1533–42. https://doi.org/10.1093/ntr/ntz202.

    Article  PubMed  Google Scholar 

  57. Brunette MF, et al. Brief, Web-Based Interventions to Motivate Smokers With Schizophrenia: Randomized Trial. JMIR Ment Health. 2020;7(2):e16524. https://doi.org/10.2196/16524.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Godin S-L, Shehata S. Adolescent cannabis use and later development of schizophrenia: An updated systematic review of longitudinal studies. J Clin Psychol. 2022;78(7):1331–40. https://doi.org/10.1002/jclp.23312.

    Article  PubMed  Google Scholar 

  59. Patel S, Khan S, Saipavankumar M, Hamid P. The Association Between Cannabis Use and Schizophrenia: Causative or Curative? A Systematic Review. Cureus. 2020;12(7):e9309. https://doi.org/10.7759/cureus.9309.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Tatar O, Bastien G, Abdel-Baki A, Huỳnh C, Jutras-Aswad D. A systematic review of technology-based psychotherapeutic interventions for decreasing cannabis use in patients with psychosis. Psychiatry Res. 2020;288:112940. https://doi.org/10.1016/j.psychres.2020.112940.

    Article  PubMed  Google Scholar 

  61. Tatar O, et al. Evaluating preferences for online psychological interventions to decrease cannabis use in young adults with psychosis: An observational study. Psychiatry Res. 2023;326:115276. https://doi.org/10.1016/j.psychres.2023.115276.

    Article  PubMed  Google Scholar 

  62. Tatar O, et al. Technology-Based Psychological Interventions for Young Adults With Early Psychosis and Cannabis Use Disorder: Qualitative Study of Patient and Clinician Perspectives. JMIR Form Res. 2021;5(4):e26562. https://doi.org/10.2196/26562.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Tatar O, et al. Reducing Cannabis Use in Young Adults With Psychosis Using iCanChange, a Mobile Health App: Protocol for a Pilot Randomized Controlled Trial (ReCAP-iCC). JMIR Res Protoc. 2022;11(11):e40817. https://doi.org/10.2196/40817.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Hides L, et al. A Web-Based Program for Cannabis Use and Psychotic Experiences in Young People (Keep It Real): Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2020;9(7):e15803. https://doi.org/10.2196/15803.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Folsom DP, et al. Prevalence and Risk Factors for Homelessness and Utilization of Mental Health Services Among 10,340 Patients With Serious Mental Illness in a Large Public Mental Health System. Am J Psychiatry. 2005;162(2):370–6. https://doi.org/10.1176/appi.ajp.162.2.370.

    Article  PubMed  Google Scholar 

  66. Hoffman L, et al. Digital Opportunities for Outcomes in Recovery Services (DOORS): A Pragmatic Hands-On Group Approach Toward Increasing Digital Health and Smartphone Competencies, Autonomy, Relatedness, and Alliance for Those With Serious Mental Illness. J Psychiatr Pract. 2020;26(2):80–8. https://doi.org/10.1097/PRA.0000000000000450.

    Article  PubMed  PubMed Central  Google Scholar 

  67. No Author. Mental Health Action Programme Gap. In: Mental Health and Substance Use. WHO. 2020. https://www.who.int/teams/mental-health-and-substance-use/treatment-care/mental-health-gap-action-programme. Accessed 18 Sep 2023.

  68. Sawyer C, et al. Using digital technology to promote physical health in mental healthcare: A sequential mixed-methods study of clinicians’ views. Early Interv Psychiatry. 2023. https://doi.org/10.1111/eip.13441.

    Article  PubMed  Google Scholar 

  69. Sin J, et al. Effect of digital psychoeducation and peer support on the mental health of family carers supporting individuals with psychosis in England (COPe-support): a randomised clinical trial. Lancet Digit Health. 2022;4(5):e320–9. https://doi.org/10.1016/S2589-7500(22)00031-0.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Thaysen-Petersen D, et al. Virtual reality-assisted cognitive behavioural therapy for outpatients with alcohol use disorder (CRAVR): a protocol for a randomised controlled trial. BMJ Open. 2023;13(3):e068658. https://doi.org/10.1136/bmjopen-2022-068658.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Scott CK, Dennis ML, Johnson KA, Grella CE. A randomized clinical trial of smartphone self-managed recovery support Services. J Subst Abuse Treat. 2020;117:108089. https://doi.org/10.1016/j.jsat.2020.108089.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Scott CK, Dennis ML, Gustafson DH. Using smartphones to decrease substance use via self-monitoring and recovery support: study protocol for a randomized control trial. Trials. 2017;18(1):374. https://doi.org/10.1186/s13063-017-2096-z.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Busse A, et al. Acceptability and feasibility of using digital technology to train community practitioners to deliver a family-based intervention for adolescents with drug use disorders during the COVID-19 pandemic. Addict Behav Rep. 2021;14:100357. https://doi.org/10.1016/j.abrep.2021.100357.

  74. No Author. Co-Occurring Disorders and Other Health Conditions. In: Co-Occuring Disorders. Substance Abuse and Mental Health Services Administration. 2023. https://www.samhsa.gov/medications-substance-use-disorders/medications-counseling-related-conditions/co-occurring-disorders. Accessed 23 Sep 2023.

  75. Naslund JA et al. Schizophrenia Assessment, Referral and Awareness Training for Health Auxiliaries (SARATHA): Protocol for a Mixed-Methods Pilot Study in Rural India. Int J Environ Res Public Health. 2022;19(22). https://doi.org/10.3390/ijerph192214936.

  76. Tyagi V, et al. Development of a Digital Program for Training Community Health Workers in the Detection and Referral of Schizophrenia in Rural India. Psychiatr Q. 2023;94(2):141–63. https://doi.org/10.1007/s11126-023-10019-w.

    Article  PubMed  Google Scholar 

Download references

Funding

No author received any funding related to this manuscript.

Author information

Authors and Affiliations

  1. Department of Global Health and Social Medicine, Harvard Medical School, Boston, USA

    Anand Chukka A.B., Soumya Choudhary M. Phil, Siddharth Dutt PhD, Ameya Bondre MSPH, MBBS, Preethi Reddy MD, Deepak Tugnawat MSW, Abhijit R. Rozatkar MD, Urvakhsh Mehta MD, PhD, Narayana Manjunatha MD, Matcheri Keshavan MD, Vikram Patel PhD, MBBS, Suresh Bada Math MD, PhD, Channaveerachari Naveen Kumar MD, Jagadisha Thirthalli MD, Anant Bhan MHSc, MBBS, John Torous MD & John A. Naslund PhD

Authors
  1. Anand Chukka A.B.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Soumya Choudhary M. Phil
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Siddharth Dutt PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ameya Bondre MSPH, MBBS
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Preethi Reddy MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Deepak Tugnawat MSW
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Abhijit R. Rozatkar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Urvakhsh Mehta MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Narayana Manjunatha MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Matcheri Keshavan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Vikram Patel PhD, MBBS
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Suresh Bada Math MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Channaveerachari Naveen Kumar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Jagadisha Thirthalli MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Anant Bhan MHSc, MBBS
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. John Torous MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. John A. Naslund PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study conception and design. The first draft of the manuscript was written by Anand Chukka and John Naslund. The data collection, revision, and final edits of the study table was completed by Soumya Choudhary and Siddharth Dutt. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to John A. Naslund PhD.

Ethics declarations

Competing Interests

No author has any competing interests outside of the disclosure forms.

Human and Animal Subjects

This article does not contain any studies with human or animal subjects performed by any

of the authors. 

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chukka, A., Choudhary, S., Dutt, S. et al. Digital Interventions for Relapse Prevention, Illness Self-Management, and Health Promotion In Schizophrenia: Recent Advances, Continued Challenges, and Future Opportunities. Curr Treat Options Psych 10, 346–371 (2023). https://doi.org/10.1007/s40501-023-00309-2

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40501-023-00309-2

Keywords

Search

Navigation